for the development of cell culture systems for influenza virus generate the master working cell bank (WCS-MDCK ATCC-52 replication, at yields suitable for vaccine production, was DU 5) . From this source, the working cell bank was produced pointed out with respect to influenza pandemic planning. Such by serial passage on microcarriers in stirred fermenters, using a production method would facilitate rapid vaccine production a protocol appropriate for industrial production. A part of the in the event of an emerging pandemic. In response to this need, working cell bank was passaged to the maximum level under we have developed a cell culture -based production process production circumstances for control reasons (extended cell for an influenza subunit vaccine, using cultured MDCK cells bank).
for virus propagation. All relevant MDCK cell banks were
The MCS, WCS, and extended cell bank were evaluated at Microbiological Associates (Stirling, UK) according to internaextensively tested for safety according to guidelines of the US tionally accepted guidelines for the use of cell lines in humans Food and Drug Administration [4] . [4 -6] [WHO], Geneva) into small-scale fermenters. The MDCK-derived The vaccines were tested for sterility, pyrogenicity, and general Study design. The present study was a prospective, randomized, double-blind, comparative study of single-dose MDCK-or egg-derived influenza subunit vaccines in healthy volunteers with normal physical examination results and without a known hypersensitivity to chicken proteins. Before and 3 weeks after immunizaorigin as determined by microbiologic tests and animal models. tests were done at NIBSC as described in [8, 9] , using turkey years). There were slightly more women in the egg-derived erythrocytes. HAI test antigens were produced in hen eggs or vaccine group (70%) than in the MDCK-derived vaccine group MDCK cells. Geometric mean titers from the duplicate determina-(60%). Prevaccination antibody titers (baseline levels) to the 2 tions were used for further statistical evaluation. Negative sera (titer õ10) were arbitrarily assigned a titer of 5. influenza vaccine strains were low and similar in both treatment of side effects is reported to be an inhibitory factor for vaccisubjects with postvaccination titer ú70%, and proportion of seroconverted subjects or subjects with §4-fold titer increase ú40%. Data in parentheses nation [13] .
are 95% confidence intervals.
Both vaccines induced a strong HAI antibody titer response, meeting all criteria for immunogenicity as stated by the European Community for licensing purposes [10] . The MDCK-derived vaccine in this study induced slightly lower absolute HAI titers than the egg-derived vaccine. This differcaused little or no problems. Only 4 subjects in each group ence, however, was not considered to be clinically relevant reported moderate or severe inconvenience after vaccination because the proportion of subjects with a titer §40 was (table 1). The cumulative variables ''any local reaction'' similar for both vaccines for each of the vaccine antigens. and ''any systemic reaction'' were similar in both treatment
More studies are needed to confirm or refute the suggested groups.
difference in absolute titers from this first study in humans. Immunogenicity. Table 2 presents the serologic response
In view of future implications, the observed safety, tolerof subjects vaccinated with MDCK-derived vaccine. The ance, and immunogenicity of the MDCK-derived influenza data presented are from HI antibody titer tests, using the vaccine justify its further development, with the potential for MDCK-derived test antigens. The European licensure criteimproved management and control of future pandemics [1 -ria for immunogenicity [10] were all exceeded, as were Euro-3]. In addition, direct propagation of human influenza field pean serologic criteria for the conventional egg-derived vacstrains on mammalian cells, such as MDCK (thus preventing cine (data not shown).
egg-adaptation), might result in influenza vaccines of inPostvaccination geometric mean titers and proportions of creased efficacy [14] . subjects with titers §40 were compared for the two vaccines, using either egg-or MDCK-derived test antigen (table 3) . Absolute titers were generally somewhat greater for the egg-
